Brent Pfeiffenberger is the founder of Neogene Therapeutics. Neogene Therapeutics has raised $110M in total funding. Latest round: Series A.
Brent Pfeiffenberger is the founder of Neogene Therapeutics, a biotechnology company focused on developing personalized T-cell receptor therapies for cancer patients. He led the company's $110 million Series A financing and established a partnership with Twist Bioscience.
Full founder directory · Investor directory · Company funding database · Fundraising library